Showing 321 - 340 results of 593 for search '(( significant decrease decrease ) OR ( significant ((fold decrease) OR (a decrease)) ))~', query time: 0.33s Refine Results
  1. 321
  2. 322

    RICTOR regulates UGCG expression via transcription factor Zinc Finger X-linked (ZFX). by Mohammad Nafees Ansari (22232505)

    Published 2025
    “…<b>(J, K)</b> Immunoblots (J) and their quantification (mean ± SEM, <i>n</i> = 3) (K) show upregulation and downregulation of UGCG upon overexpression and silencing of ZFX in MCF-7_ZFX<sup>OE</sup> and MCF-7_ZFX<sup>SL</sup> cells. <b>(L, M)</b> Fold change (mean ± SEM, <i>n</i> = 5) in ceramides (L) and glucosylceramides (M) confirms a decrease in ceramides and an increase in glucosylceramides in MCF-7_ZFX<sup>OE</sup> cells. …”
  3. 323

    Ydj1 acetylation alters interactions with client proteins. by Siddhi Omkar (12413434)

    Published 2024
    “…Interactors are colored according to change in interaction as follows: green (significant increase), red (significant decrease), or purple (no significant change) 6KQ/6KR. …”
  4. 324
  5. 325

    Table 1_Fibromyalgia diagnosis from a multi-omics approach: a gut feeling.pdf by Elena Durán-González (17438448)

    Published 2025
    “…After the raw data analysis, proteins with statistically significant differential abundance and a fold change over 1.2 (20% increase in fibromyalgia compared with control samples) or under 0.8 (20% decrease in fibromyalgia compared with control samples) in fibromyalgia were selected. …”
  6. 326
  7. 327
  8. 328
  9. 329

    Discovery of Tamsulosin Derivatives with Shifted Selectivity from the α<sub>1</sub>‑Adrenergic Receptor to ANO1 as Potent Antiosteoporotic Agents by Chaoquan Tian (21009122)

    Published 2025
    “…The potency of compound <b>10</b> against ANO1 was comparable to that of <b>Tam</b> (IC<sub>50</sub>: 4.57 vs 7.22 μM), but its selectivity over α<sub>1</sub>-AR was significantly improved. Compared with <b>Tam</b>, the potency of compound <b>10</b> against α<sub>1A</sub>-, α<sub>1B</sub>-, and α<sub>1D</sub>-AR decreased by 118-fold, 642-fold, and 10,000-fold, respectively. …”
  10. 330

    Discovery of Tamsulosin Derivatives with Shifted Selectivity from the α<sub>1</sub>‑Adrenergic Receptor to ANO1 as Potent Antiosteoporotic Agents by Chaoquan Tian (21009122)

    Published 2025
    “…The potency of compound <b>10</b> against ANO1 was comparable to that of <b>Tam</b> (IC<sub>50</sub>: 4.57 vs 7.22 μM), but its selectivity over α<sub>1</sub>-AR was significantly improved. Compared with <b>Tam</b>, the potency of compound <b>10</b> against α<sub>1A</sub>-, α<sub>1B</sub>-, and α<sub>1D</sub>-AR decreased by 118-fold, 642-fold, and 10,000-fold, respectively. …”
  11. 331

    Discovery of Tamsulosin Derivatives with Shifted Selectivity from the α<sub>1</sub>‑Adrenergic Receptor to ANO1 as Potent Antiosteoporotic Agents by Chaoquan Tian (21009122)

    Published 2025
    “…The potency of compound <b>10</b> against ANO1 was comparable to that of <b>Tam</b> (IC<sub>50</sub>: 4.57 vs 7.22 μM), but its selectivity over α<sub>1</sub>-AR was significantly improved. Compared with <b>Tam</b>, the potency of compound <b>10</b> against α<sub>1A</sub>-, α<sub>1B</sub>-, and α<sub>1D</sub>-AR decreased by 118-fold, 642-fold, and 10,000-fold, respectively. …”
  12. 332
  13. 333

    MDSC inhibition was correlated with Trp metabolism in 17ZR101-infected lungs. by Qi Xu (134661)

    Published 2025
    “…Fold change > 1.2 and FDR-adjusted P-value < 0.05 considered significant. …”
  14. 334

    Primer pairs for RT-qPCR. by Yoichi Kurokawa (22290520)

    Published 2025
    “…Conversely, exposure to endogenous prooxidants (dopamine and adrenaline), certain food-derived polyphenols (chrysin and 3-<i><i>O</i></i>-methylquercetin), or 1,2-naphthoquinone led to a significant decrease (<0.5-fold) in Rmst expression. …”
  15. 335

    RT-qPCR data tables. by Yoichi Kurokawa (22290520)

    Published 2025
    “…Conversely, exposure to endogenous prooxidants (dopamine and adrenaline), certain food-derived polyphenols (chrysin and 3-<i><i>O</i></i>-methylquercetin), or 1,2-naphthoquinone led to a significant decrease (<0.5-fold) in Rmst expression. …”
  16. 336

    Minimal data set. by Zhaoping Meng (4875040)

    Published 2025
    “…Twenty-two differential metabolites (VIP ≥ 1) were identified using untargeted metabolomics. 3 primary metabolites, namely mannose, pyruvate, and shikimic acid, together with 2 secondary metabolites, phenylalanine and mevalonic acid, were observed to decrease. 17 secondary metabolites, including Schisandrin A, Schisandrin B, Schisandrin C, Gomisin D, Gomisin G, Gomisin H, Benzoylgomisin H, Benzoylgomisin O,Angeloylgomisin P, Catechin, Isorhamnetin, Luteolin, Cinnamic acid, Hydroxycinnamic acid, Hexahydrocurcumin, Coniferyl alcohol, Phenylalanine, Terpinolene and Mevalonic acid, exhibited increases in their levels by 10.64, 1.84, 1.40, 1.64, 4.46, 8.18, 1.72, 10.20, 2.08, 1.27, 1.57, 1.18, 2.01, 1.12, 1.88, 1.15, and 3.17-fold, respectively. …”
  17. 337
  18. 338

    Validation of model predictions of growth during infusion of hypertrophic agonists with and without receptor blockers. by Johane H. Bracamonte (12883844)

    Published 2025
    “…By contrast, the model prediction of nearly equal likelihood that ERA increases or decreases NE-induced growth appears to contradict a significant reported decrease in the only available experimental study [<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1012390#pcbi.1012390.ref121" target="_blank">121</a>]. …”
  19. 339

    Key biological processes and genes are identified in TGF-β1-induced fibrosis via transcriptome analysis. by Dong-Hee Han (140305)

    Published 2024
    “…<p>After treatment with 1 and 5 ng/mL TGF-β1 for 48 h, mRNA transcriptome analysis was performed. <b>(A)</b> Differentially expressed genes (DEGs; ≥2 folds, ≥7 normalized data value) significantly altered by TGF-β1 treatment were depicted by a Venn diagram. …”
  20. 340

    Care quality. by Youssef Hbid (18803761)

    Published 2025
    “…Stroke multidisciplinary access increased during the first lockdown but decreased in subsequent periods. Access to thrombectomy sequentially increased across time periods; by 40% during first lockdown (adjusted Odd-Ratio: 1.4; 95% CI:1.24–1.58), second lockdown (aOR: 1.77; 1.66–1.92), and 2-folds post-lockdown (aOR: 2.03; 1.92–2.15). …”